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SUMMARY – We present an isolate of Klebsiella pneumoniae OXA-48 isolated in a 68-year-old 
man who underwent radical prostatectomy due to prostate cancer. Th e antibiotic susceptibility testing 
to a wide range of antibiotics was performed by disk diff usion method and determination of minimal 
inhibitory concentrations. Th e isolate was classifi ed as multidrug-resistant. It showed intermediate 
susceptibility to imipenem and meropenem, resistance to ertapenem, and sensitivity only to colistin, 
amikacin, and trimethoprim-sulfamethoxazole. Th e isolate was positive for ESBLs, negative for 
AmpC. Polymerase chain reaction and sequencing revealed blaOXA-48, blaCTX-M-15 and blaSHV-11. Th e plas-
mid encoding OXA-48 ß-lactamase did not belong to any known PCR-based replicon typing. Ac-
cording to genotyping, the isolate belonged to ST37.
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Introduction
Carbapenems are the drugs of choice for the treat-
ment of infections caused by multiresistant gram-neg-
ative bacilli1. Carbapenemases involved in acquired 
resistance belong to Ambler class A serin ß-lactamases 
(KPC, SME, GES, IMI, NMC), class B metallo-ß-
-lactamases (MBL) of IMP, VIM or NDM family, 
or OXA-48-like ß-lactamases belonging to class D ß-
lactamases2.
Resistance phenotypes of carbapenemase produc-
ing Enterobacteriaceae (CRE) range from extreme mul-
tiresistance to resistance only to ß-lactams2. Th e fi rst 
carbapenem-resistant Enterobacteriacae species in Croa-
tia was NDM-1 producing Klebsiella (K.) pneumoniae 
isolated in 2008 at the Zagreb University Hospital 
Center3. Later on, in 2011, a KPC-2-positive K. pneu-
moniae was isolated at the same institution4. Th is ob-
servation gave rise to a multicenter study on carbapen-
em-resistance in Enterobacteriaceae in Croatia, con-
ducted in 2011-2012, which revealed the predomi-
nance of VIM-1 ß-lactamase in two large hospital 
centers (Zagreb and Split), but only KPC ß-lactamase 
was reported at Sestre milosrdnice University Hospital 
Center5. In 2013, an outbreak of VIM-1 producing 
Enterobacter (E.) cloacae was reported at Split Univer-
sity Hospital Center6. Following emergence of KPC 
ß-lactamases in 2013, the fi rst outbreak associated 
with KPC-2 was observed at Sestre milosrdnice Uni-
versity Hospital Center in 20147. Carbapenemase-
producing Enterobacteriacae were further identifi ed in 
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Sestre milosrdnice University Hospital Center, posing 
serious therapeutic problem for the clinicians.
Carbapenemase producing Enterobacteriaceae often 
co-harbor resistance genes encoding extended-spec-
trum ß-lactamases (ESBLs), plasmid-mediated AmpC 
ß-lactamases and qnr genes responsible for reduced 
susceptibility to fl uoroqinolones2.
Sestre milosrdnice University Hospital Center is a 
hospital with 1200 beds in all medical specialties. It 
serves a great part of the Zagreb population and acts as 
a referral hospital for the whole Croatia for specifi c 
patients/procedure groups, thus covering a catchment 
population of about 4,000,000 people.
Case Report
A 68-year-old man without serious illnesses in his 
medical history and no prior hospitalization in other 
hospitals was admitted for the fi rst time to Depart-
ment of Urology, Sestre milosrdnice University Hospi-
tal Center, for elevated prostate specifi c antigen (PSA) 
level. During his fi rst hospitalization, transrectal ultra-
sound guided prostate biopsy was performed. After 
biopsy, the patient experienced no discomfort or dys-
uria. His diuresis was regular and he was discharged 
home while expecting his histopathologic report. Th e 
antibiotic ciprofl oxacin was prescribed one day prior to 
biopsy and for the next fi ve days. Th e dosage was 500 
mg two times daily. No urine cultures were performed 
prior to biopsy, as the patient reported no symptoms 
related to urinary tract infection.
Histopathologic fi nding revealed prostatic cancer 
and the patient was admitted for the second time. 
Radical prostatectomy was performed. Th e procedure 
was routine, with no complications. One hour prior to 
surgery, the patient received a single dose of 750 mg of 
cefuroxime. Since no fever was present during his stay 
at the Department and his routine urine culture sam-
pled at admission was sterile, no further antibiotics 
were administered.
Two weeks after discharge from the hospital, the 
patient presented to the Department due to obstruc-
tive voiding symptoms. No dysuria or fever was pres-
ent, so a Foley catheter was placed. One week after 
catheter placement, it was removed and the patient 
reported normal urine voiding. Abdominal ultrasound 
found no residual urine after voiding.
One month after surgical treatment, the patient 
was admitted to the Department as an emergency case. 
His diagnosis upon admission was as follows: urinary 
retention caused by urinary tract infection. Immedi-
ately upon admission to the same Department, his 
urine was sampled for microbiological analysis. Th e 
specimen was sent to Department of Microbiology, 
Parasitology and Hospital Infections, Sestre milosrd-
nice University Hospital Center and processed. Urine 
culture revealed K. pneumoniae in the quantity of 105. 
According to the zone diameter breakpoint in disk dif-
fusion method, the K. pneumoniae isolate was resistant 
to the following antibiotics: ampicillin, amoxicillin-
clavulanic acid, piperacillin-tazobactam, cefazolin, ce-
furoxime iv., ceftibuten, cefi xime, ceftriaxone, ceftazi-
dime, cefepime, ertapenem, norfl oxacin, levofl oxacin, 
ciprofl oxacin, and gentamicin. It was susceptible to 
amikacin, trimethoprim-sulfamethoxazole and colis-
tin (susceptibility to colistin was determined by E-
test). Th e isolate showed intermediate susceptibility to 
imipenem and meropenem. Th e isolate of K. pneu-
moniae was sent to the Zagreb University Hospital 
Center for further investigation and OXA-48 ß-lacta-
mase was identifi ed.
Trimethoprim-sulfamethoxazole per os was admin-
istered. Urethrocystoscopy was done to exclude me-
chanical obstruction (e.g., bladder-urethra anastomo-
sis sclerozation or bladder calculi) as the cause of uri-
nary retention. No obstruction was found. Upon com-
pletion of antibiotic therapy, the patient had no 
residual urine after voiding, no pain during voiding, 
and was fully continent, suggesting a conclusion that 
urinary tract infection was the cause of urinary reten-
tion.
Hospital infection control measures were recom-
mended, including isolation of the patient, cleaning of 
the ward and equipment, hygienic measures, use of 
gloves and gowns by medical personnel, etc.
Methods
Identifi cation and antimicrobial susceptibility testing
Th e isolate of K. pneumoniae was identifi ed using 
standard biochemical methods. Th e antibiotic suscep-
tibility testing to a wide range of antibiotics was per-
formed by disk diff usion method and broth microdilu-
tion method in 96-well microtiter plates and inter-
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preted according to the Clinical and Laboratory Stan-
dards Institute (CLSI) breakpoints8-10. Th e isolate was 
classifi ed as multidrug-resistant, extensively-drug-re-
sistant or pan-drug-resistant according to Magiorakis 
et al.11 .
Phenotypic tests for detection of ESBLs, plasmid-
mediated AmpC ß-lactamases and carbapenemases
Double disk synergy test (DDST)12 and CLSI 
combined disk test with the addition of clavulanic 
acid10 were performed to detect ESBLs. Plasmid-me-
diated AmpC ß-lactamases were detected by com-
bined disk test using cephalosporin disks combined 
with PBA (3-aminophenylboronic acid)13. Modifi ed 
Hodge test (MHT) was used to screen for the produc-
tion of carbapenemases14. Additionally, the isolate was 
tested by combined disk tests with imipenem and me-
ropenem alone and combined with 3-aminophenylbo-
ronic acid test (PBA), 0.1 M EDTA or both to screen 
for KPC, MBLs, or simultaneous production of KPC 
and MBL, respectively15,16.
Conjugation
Th e transferability of meropenem resistance was 
determined by conjugation (broth mating method) 
employing E. coli A15R- strain resistant to rifampicin 
and E. coli J65 resistant to sodium azide17. Transconju-
gant was selected on combined plates containing me-
ropenem (1 mg/L) to inhibit the growth of recipient 
strain and rifampicin (256 mg/L) or sodium azide 
(100 mg/L) to suppress donor strains.
Molecular detection of resistance genes
Th e genes conferring resistance to ß-lactams in-
cluding broad spectrum and extended-spectrum ß-
lactamases (blaSHV, blaTEM, blaCTX-M and blaPER-1)18-22, 
plasmid-mediated AmpC ß-lactamases23, class A car-
bapenemases (blaKPC, blaSME, blaIMI and blaNMC,)24-26, 
class B (blaVIM, blaIMP and blaNDM)27-29, and carbapenem 
hydrolyzing oxacillinases (blaOXA-48)30 and to fl uoroqui-
nolones (qnrA, qnrB and qnrS)31 were determined by 
PCR using protocols and conditions as described pre-
viously. Th e DNA was extracted by boiling method. 
Amplicons were column-purifi ed with Qiagen DNA 
purifi cation kit (Inel, Zagreb, Croatia) and sequenced 
directly in Eurofi n sequencing service (Ebersberg, 
Germany).
Characterization of plasmids
Plasmids were extracted with Qiagen Mini kit ac-
cording to the manufacturer’s instructions. PCR-based 
replicon typing (PBRT) according to Carattoli et al.32 
was applied to type the resistance plasmids carrying 
carbapenemase genes.
Genotyping
Th e isolate was also genotyped by MSLT according 
to Diancourt et al.33.
Results
Antimicrobial susceptibility testing
Determination of minimal inhibitory concentra-
tions (MICs) revealed resistance to amoxicillin alone 
and combined with clavulanic acid, piperacillin, piper-
acillin/tazobactam, cefazolin, cefuroxime, ceftazidime, 
cefotaxime and cefepime with MIC of >128 mg/L, 
ertapenem (16 mg/L), gentamicin (>128 mg/L) and 
ciprofl oxacin (32 mg/L), as shown in Table 1. Mero-
penem and imipenem showed intermediate suscepti-
bility (2 mg/L).
Table 1. Minimal inhibitory concentrations (MICs) 
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Phenotypic tests for detection of ESBLs, 
plasmid-mediated AmpC ß-lactamases 
and carbapenemases
Th e isolate was positive for ESBLs in inhibitor 
based test with clavulanic acid (an increase of inhibi-
tion zone around cephalosporin disks in the presence 
of clavulanate for 10 to 15 mm), but negative for 
AmpC in inhibitor based test with phenylboronic acid.
Conjugation
Th e K. pneumoniae isolate did not transfer merope-
nem resistance to E. coli recipient strain.
Molecular detection of resistance genes
Polymerase chain reaction and sequencing revealed 
blaOXA-48, blaCTX-M-15 and blaSHV-11 with the latter being 
chromosomally encoded in K. pneumoniae.
Characterization of plasmids
Th e plasmid encoding OXA-48 ß-lactamase did 
not belong to any known PBRT.
Genotyping
Th e isolate belonged to ST37.
Discussion
We report a case of urinary tract infection in a pa-
tient with prostate cancer associated with K. pneu-
moniae positive for OXA-48 ß-lactamase. OXA-48 
was fi rst reported in Turkey in 200130,34, but later it 
spread in many European countries such as France35,36, 
Israel2, Italy37, Spain38, Germany39, Switzerland2, Bel-
gium40, Th e Netherlands41, Ireland42, Sweden, Den-
mark, Norway, Finland2 and also in Slovenia43 as a 
Croatia neighbor country. In Belgium and Th e Neth-
erlands, it is the most prevalent type of carbapenemase. 
Croatia was spared from this type of carbapenemase 
until 2014. Our K. pneumoniae with OXA-48 K. pneu-
moniae originating belonged to ST37, unlike UK 
where it belonged to ST2212, Th e Netherlands and 
France where it was allocated to ST395, and Belgium 
where it belonged to ST14736,40. Laboratory detection 
of OXA-48 ß-lactamase poses a serious problem be-
cause of the low level carbapenem resistance and 
sometimes lack of additional ESBL. In our report, the 
strain had elevated carbapenem MICs co-harbored 
CTX-M-15 ß-lactamase, which is responsible for re-
sistance to expanded-spectrum cephalosporins. Th e 
majority of OXA-48 producing European isolates 
 coproduce CTX-M-15 or SHV-12 ß-lactamase38. 
OXA-48 ß-lactamase is usually plasmid-mediated and 
the majority of plasmids encoding it belong to W, P 
or L/M incompatibility group2,38. Transposon Tn1999 
is responsible for the mobilization of blaOXA-48 gene36. 
However, our isolate did not transfer resistance to E. 
coli recipient strain and the plasmid extraction did not 
yield any product in PCR for plasmid incompatibility 
typing. PCR for qnr genes was negative indicating that 
fl uoroquinolone resistance was probably due to other 
mechanism such as mutations in gyrA or parC genes.
Microbiological laboratories should be able to de-
tect and characterize carbapenemase producing En-
terobacteriaceae in order to prevent the spread of these 
important ‘superbugs’.
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Sažetak
KLEBSIELLA PNEUMONIAE OXA-48 KOD UROLOŠKOG BOLESNIKA: PRIKAZ SLUČAJA
I. Jajić, A. Benčić, M. Siroglavić, G. Zarfel, B. Ružić, I. Pezelj i B. Bedenić
Prikazan je izolat Klebsiella pneumoniae OXA-48 izoliran iz mokraće 68-godišnjeg muškaraca kojemu je napravljena 
 radikalna prostatektomija zbog raka prostate. Testiranje osjetljivosti izolata na velik broj antibiotika provedeno je metodom 
disk difuzije kao i metodom određivanja minimalnih inhibitornih koncentracija. Izolat je klasifi ciran kao višestruko rezisten-
tan. Smanjeno je osjetljiv na imipenem i meropenem, rezistentan na ertapenem, a osjetljiv samo na kolistin, amikacin i 
trimetoprim+sulfometoksazol. Izolat proizvodi ESBL, a ne proizvodi AmpC. Lančana reakcije polimeraze i sekvenciranje je 
pokazalo blaOXA-48, blaCTX-M-15 i blaSHV-11. Plazmidno kodirana OXA-48 ß-laktamaza ne pripada niti jednom poznatom PBRT. 
Prema genotipizaciji, izolat pripada ST37.
Ključne riječi: Klebsiella pneumoniae – izolacija i purifi kacija; Klebsiella infekcije; Prikazi slučaja
